Ingrid Domke
About
In The Last Decade
Ingrid Domke
26 papers receiving 369 citations
Peers
Comparison fields: 5 of 83
- Epidemiology 156
- Pathology and Forensic Medicine 89
- Molecular Biology 75
- Immunology 55
- Nephrology 44
Countries citing papers authored by Ingrid Domke
This map shows the geographic impact of Ingrid Domke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Domke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Domke more than expected).
Fields of papers citing papers by Ingrid Domke
This network shows the impact of papers produced by Ingrid Domke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Domke. The network helps show where Ingrid Domke may publish in the future.
Co-authorship network of co-authors of Ingrid Domke
This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Domke. A scholar is included among the top collaborators of Ingrid Domke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Domke. Ingrid Domke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 14 | |
| 3 | 20 | |
| 4 | 0 | |
| 5 | 10 | |
| 6 | 13 | |
| 7 | 15 | |
| 8 | 94 | |
| 9 | Clinical evaluation of the Elecsys CA 15-3 test in breast cancer patients. | 27 |
| 10 | Therapeutic drug monitoring on COBAS INTEGRA 400--evaluation results. | 11 |
| 11 | Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS. | 1 |
| 12 | Multicenter evaluation of the Elecsys CA 125 II assay. | 3 |
| 13 | 8 | |
| 14 | Multicenter evaluation of five new turbidimetric assays for alpha-1-acid glycoprotein, alpha-1-antitrypsin, ceruloplasmin, haptoglobin and prealbumin | 2 |
| 15 | 9 | |
| 16 | Detetermination of reference values for a colorimetric fructosamine assay | 2 |
| 17 | Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and a fluorescence polarization immunoassay. | 2 |
| 18 | 22 | |
| 19 | 3 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.